These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 6369734)
101. Advisability of switching of i.p. insulin in to CAPD. Quellhorst E Semin Dial; 2002; 15(5):376. PubMed ID: 12358646 [No Abstract] [Full Text] [Related]
102. [Insulin therapy in 1984]. Grimaldi A Ann Med Interne (Paris); 1984; 135(3):217-34. PubMed ID: 6378010 [No Abstract] [Full Text] [Related]
103. [Intensive insulin therapy in the diabetic child]. Bougnères PF Union Med Can; 1985 Oct; 114(10):821-8. PubMed ID: 3909569 [No Abstract] [Full Text] [Related]
105. Comparison of continuous subcutaneous insulin infusion treatment and multiple daily injection treatment on the progression of diabetic complications in Japanese patients with juvenile-onset type 1 diabetes mellitus. Masuda T; Katakami N; Taya N; Miyashita K; Takahara M; Kato K; Kuroda A; Matsuhisa M; Shimomura I J Diabetes Investig; 2022 Sep; 13(9):1528-1532. PubMed ID: 35474612 [TBL] [Abstract][Full Text] [Related]
106. Nighttime continuous subcutaneous insulin infusion revisited: a strategy for improving insulin delivery. Schiffrin A Diabetes Care; 2000 May; 23(5):571-3. PubMed ID: 10834409 [No Abstract] [Full Text] [Related]
107. Use of continuous insulin infusion therapy to achieve improved metabolic control. Chiumello G; Meschi F; Beccaria L; Pellini C; di Natale B; Bianchi C Panminerva Med; 1984; 26(3):171-5. PubMed ID: 6522078 [No Abstract] [Full Text] [Related]
108. Continuous glucose monitoring--coming of age. Wolpert HA N Engl J Med; 2010 Jul; 363(4):383-4. PubMed ID: 20587584 [No Abstract] [Full Text] [Related]
109. [Glycosylated proteins and control of the diabetic: use of continuous flow insulin pumps by the subcutaneous route]. Maudelonde T; Menez JF; Meskar A; Tater D; Lucas D; Barbou LG; Bercovici JP Diabete Metab; 1983 Sep; 9(3):193-8. PubMed ID: 6653857 [TBL] [Abstract][Full Text] [Related]
110. A self-controlled study of the effect of continuous subcutaneous insulin infusion on diabetic neuropathy. Haug PJ; Kelly TM; Cannon RB; Edwards CQ J Neurol Sci; 1987 Dec; 82(1-3):123-32. PubMed ID: 3440863 [TBL] [Abstract][Full Text] [Related]
111. Meeting the problems of first-generation insulin infusion pumps: clinical trial of a new miniature infuser. Bending JJ; Pickup JC; Keen H; Rothwell D; Sutherland IA Diabetes Care; 1983; 6(5):452-8. PubMed ID: 6400705 [TBL] [Abstract][Full Text] [Related]
112. Diabetes in the young: from Leicester to Siena (via Oslo, Bethesda and Hvidore). Swift PG Acta Biomed; 2005; 76 Suppl 3():7-13. PubMed ID: 16915789 [No Abstract] [Full Text] [Related]
113. Role of Automation/Technology in Day-to-Day Diabetes Care. Dadlani V; Kudva YC Diabetes Technol Ther; 2016 May; 18(5):273-5. PubMed ID: 27028696 [No Abstract] [Full Text] [Related]
115. [Treatment of diabetes mellitus type 1 by long-term infusion of insulin]. Krzymień J; Wójcicki J; Plechanow J; Regulski M; Szymerska E; Tracz M Pol Arch Med Wewn; 1989 Apr; 81(4):223-30. PubMed ID: 2626348 [TBL] [Abstract][Full Text] [Related]
116. [Current orientations of treatment in pregnancy in the diabetic patient]. Menato G; Trossarelli GF; Carta Q; Meriggi E Minerva Ginecol; 1983 Nov; 35(11):705-10. PubMed ID: 6669306 [No Abstract] [Full Text] [Related]
118. Health locus of control and glycosylated haemoglobin concentration of implantable insulin pump recipients in Austria. Meize-Grochowski AR J Adv Nurs; 1990 Jul; 15(7):804-7. PubMed ID: 2394887 [TBL] [Abstract][Full Text] [Related]